Gene · 10399
Papers3,110
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,110
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| La-related protein 4 is enriched in vaccinia virus factories and is required for efficient viral replication in primary human fibroblasts. | Microbiol Spectr | 2023 | 37594266 | PubTator, text mining | PubMed |
| TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK/ERK signaling. | Cell Death Dis | 2023 | 37591850 | PubTator, text mining | PubMed |
| Hypoxia-driven ncRNAs in breast cancer. | Front Oncol | 2023 | 37583933 | PubTator, text mining | PubMed |
| The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19. | Front Pharmacol | 2023 | 37583901 | PubTator, text mining | PubMed |
| Molecular mechanisms of alcohol's effects on the human body: A review and update. | J Biochem Mol Toxicol | 2023 | 37578200 | PubTator, text mining | PubMed |
| KITENIN promotes aerobic glycolysis through PKM2 induction by upregulating the c-Myc/hnRNPs axis in colorectal cancer. | Cell Biosci | 2023 | 37553596 | PubTator, text mining | PubMed |
| The value of RACK1 and peripheral blood M2/M1 monocyte ratio on the prognosis of patients with oral squamous cell carcinoma. | Pak J Pharm Sci | 2023 | 37548201 | PubTator, text mining | PubMed |
| Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities. | Front Immunol | 2023 | 37545507 | PubTator, text mining | PubMed |
| Analysis of Differential Gene Expression and Core Canonical Pathways Involved in the Epithelial to Mesenchymal Transition of Triple Negative Breast Cancer Cells by Ingenuity Pathway Analysis. | Comput Mol Biosci | 2023 | 37538932 | PubTator, text mining | PubMed |
| Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment. | Front Cell Dev Biol | 2023 | 37538397 | PubTator, text mining | PubMed |
| OTUB1's role in promoting OSCC development by stabilizing RACK1 involves cell proliferation, migration, invasion, and tumor-associated macrophage M1 polarization. | Cell Signal | 2023 | 37532135 | PubTator, text mining | PubMed |
| Differential proteomics argues against a general role for CD9, CD81 or CD63 in the sorting of proteins into extracellular vesicles. | J Extracell Vesicles | 2023 | 37525398 | PubTator, text mining | PubMed |
| Isobutyric acid promotes colorectal cancer metastasis through activating RACK1. | Cancer Sci | 2023 | 37519194 | PubTator, text mining | PubMed |
| Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets. | FEBS Open Bio | 2023 | 37517032 | PubTator, text mining | PubMed |
| Titanium Particles Modulate Lymphocyte and Macrophage Polarization in Peri-Implant Gingival Tissues. | Int J Mol Sci | 2023 | 37511404 | PubTator, text mining | PubMed |
| The Role of ARHGAP1 in Rho GTPase Inactivation during Metastasizing of Breast Cancer Cell Line MCF-7 after Treatment with Doxorubicin. | Int J Mol Sci | 2023 | 37511111 | PubTator, text mining | PubMed |
| The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential. | Biomolecules | 2023 | 37509175 | PubTator, text mining | PubMed |
| Ribonucleoprotein Granules: Between Stress and Transposable Elements. | Biomolecules | 2023 | 37509063 | PubTator, text mining | PubMed |
| Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies. | Cells | 2023 | 37508519 | PubTator, text mining | PubMed |
| Identifying the Common Cell-Free DNA Biomarkers across Seven Major Cancer Types. | Biology (Basel) | 2023 | 37508365 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10399/papers?page=13